Business
Director/PDMR Shareholding
Director/PDMR Shareholding.
About this update from Surgical Innovations Group Plc
[{"type":"text","content":"\n \n \n \n \n \n \n \n \n Surgical Innovations Group plc\n \n \n \n (\"Surgical Innovations\", \"SI\" or the \"Company\")\n \n \n \n \n Director/PDMR Shareholding\n \n \n \n Surgical Innovations Group plc (AIM: SUN), the designer, manufacturer and distributor of innovative medical technology for minimally invasive surgery (\"MIS\"), was notified on the 6 May 2022 that on 26 April 2022 Michael McMahon, Non-Executive Director, purchased 449,333 of shares in Surgical Innovations (the \"Ordinary Shares\") at a price of 2.22 pence per share.\n \n \n Following this transaction, Michael McMahon has a combined beneficial holding in the Company of 19,430,962 Ordinary Shares, representing approximately 2.08% of the issued share capital of the Company.\n \n \n \n For further information please contact:\n \n \n \n \n \n \n \n \n \n Surgical Innovations Group plc\n \n \n \n \n \n \n www sigroupplc com\n \n \n \n \n \n \n \n \n David Marsh, CEO\n \n \n \n \n Tel: 0113 230 7597\n \n \n \n \n \n \n Charmaine Day, CFO\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Singer Capital Markets (Nominated Adviser & Broker)\n \n \n \n \n Tel: 020 7496 3000\n \n \n \n \n \n \n Aubrey Powell / Rachel Hayes\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Walbrook PR (Financial PR & Investor Relations)\n \n \n \n \n \n Tel: 020 7933 8780 or\n \n \n \n [email protected]\n \n \n \n \n \n \n \n \n Paul McManus / Lianne Applegarth\n \n \n \n \n Mob: 07980 541 893 / 07584 391 303\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n 1\n \n \n Details of the person discharging managerial responsibilities/person closely associated\n \n \n \n \n a)\n \n \n Name\n \n \n Michael McMahon\n \n \n \n \n 2\n \n \n Reason for the notification\n \n \n \n \n a)\n \n \n Position/status\n \n \n Non-Executive Director\n \n \n \n \n b)\n \n \n Initial notification/ Amendment\n \n \n Initial Notification\n \n \n \n \n 3\n \n \n Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor\n \n \n \n \n a)\n \n \n Name\n \n \n Surgical Innovations Group plc\n \n \n \n \n b)\n \n \n LEI\n \n \n 2138004GHGUH3HUZE156\n \n \n \n \n 4\n \n \n Details of the transaction(s): section to be repeated ...